20 results on '"Lobón, Irene"'
Search Results
2. Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions
- Author
-
Marshall, Christian R., Merico, Daniele, Thiruvahindrapuram, Bhooma, Wang, Zhouzhi, Scherer, Stephen W., Howrigan, Daniel P, Ripke, Stephan, Bulik-Sullivan, Brendan, Farh, Kai-How, Fromer, Menachem, Goldstein, Jacqueline I., Huang, Hailiang, Lee, Phil, Daly, Mark J., Neale, Benjamin M., Belliveau, Richard A., Jr., Bergen, Sarah E., Bevilacqua, Elizabeth, Chambert, Kimberley D., O'Dushlaine, Colm, Scolnick, Edward M., Smoller, Jordan W., Moran, Jennifer L., Palotie, Aarno, Petryshen, Tracey L., Wu, Wenting, Greer, Douglas S., Antaki, Danny, Shetty, Aniket, Gujral, Madhusudan, Brandler, William M., Malhotra, Dheeraj, Fuentes Fajarado, Karin V., Maile, Michelle S., Holmans, Peter A., Carrera, Noa, Craddock, Nick, Escott-Price, Valentina, Georgieva, Lyudmila, Hamshere, Marian L., Kavanagh, David, Legge, Sophie E., Pocklington, Andrew J., Richards, Alexander L., Ruderfer, Douglas M., Williams, Nigel M., Kirov, George, Owen, Michael J., Pinto, Dalila, Cai, Guiqing, Davis, Kenneth L., Drapeau, Elodie, Friedman, Joseph I, Haroutunian, Vahram, Parkhomenko, Elena, Reichenberg, Abraham, Silverman, Jeremy M., Buxbaum, Joseph D., Domenici, Enrico, Agartz, Ingrid, Djurovic, Srdjan, Mattingsdal, Morten, Melle, Ingrid, Andreassen, Ole A., Jönsson, Erik G., Söderman, Erik, Albus, Margot, Alexander, Madeline, Laurent, Claudine, Levinson, Douglas F., Amin, Farooq, Atkins, Joshua, Cairns, Murray J., Scott, Rodney J., Tooney, Paul A., Wu, Jing Qin, Bacanu, Silviu A., Bigdeli, Tim B., Reimers, Mark A., Webb, Bradley T., Wolen, Aaron R., Wormley, Brandon K., Kendler, Kenneth S., Riley, Brien P., Kähler, Anna K., Magnusson, Patrik K.E., Hultman, Christina M., Bertalan, Marcelo, Hansen, Thomas, Olsen, Line, Rasmussen, Henrik B., Werge, Thomas, Mattheisen, Manuel, Black, Donald W., Bruggeman, Richard, Buccola, Nancy G., Buckner, Randy L., Roffman, Joshua L., Byerley, William, Cahn, Wiepke, Kahn, René S, Strengman, Eric, Ophoff, Roel A., Carr, Vaughan J., Catts, Stanley V., Henskens, Frans A., Loughland, Carmel M., Michie, Patricia T., Pantelis, Christos, Schall, Ulrich, Jablensky, Assen V., Kelly, Brian J., Campion, Dominique, Cantor, Rita M., Cheng, Wei, Cloninger, C. Robert, Svrakic, Dragan M, Cohen, David, Cormican, Paul, Donohoe, Gary, Morris, Derek W., Corvin, Aiden, Gill, Michael, Crespo-Facorro, Benedicto, Crowley, James J., Farrell, Martilias S., Giusti-Rodríguez, Paola, Kim, Yunjung, Szatkiewicz, Jin P., Williams, Stephanie, Curtis, David, Pimm, Jonathan, Gurling, Hugh, McQuillin, Andrew, Davidson, Michael, Weiser, Mark, Degenhardt, Franziska, Forstner, Andreas J., Herms, Stefan, Hoffmann, Per, Hofman, Andrea, Cichon, Sven, Nöthen, Markus M., Del Favero, Jurgen, DeLisi, Lynn E., McCarley, Robert W., Levy, Deborah L., Mesholam-Gately, Raquelle I., Seidman, Larry J., Dikeos, Dimitris, Papadimitriou, George N., Dinan, Timothy, Duan, Jubao, Sanders, Alan R., Gejman, Pablo V., Gershon, Elliot S., Dudbridge, Frank, Eichhammer, Peter, Eriksson, Johan, Salomaa, Veikko, Essioux, Laurent, Fanous, Ayman H., Knowles, James A., Pato, Michele T., Pato, Carlos N., Frank, Josef, Meier, Sandra, Schulze, Thomas G., Strohmaier, Jana, Witt, Stephanie H., Rietschel, Marcella, Franke, Lude, Karjalainen, Juha, Freedman, Robert, Olincy, Ann, Freimer, Nelson B., Purcell, Shaun M., Roussos, Panos, Stahl, Eli A., Sklar, Pamela, Giegling, Ina, Hartmann, Annette M., Konte, Bettina, Rujescu, Dan, Godard, Stephanie, Hirschhorn, Joel N., Pers, Tune H., Price, Alkes, Esko, Tõnu, Gratten, Jacob, Lee, S. Hong, Visscher, Peter M., Wray, Naomi R., Mowry, Bryan J., de Haan, Lieuwe, Meijer, Carin J., Hansen, Mark, Ikeda, Masashi, Iwata, Nakao, Joa, Inge, Kalaydjieva, Luba, Keller, Matthew C., Kennedy, James L., Zai, Clement C., Knight, Jo, Lerer, Bernard, Liang, Kung-Yee, Lieberman, Jeffrey, Stroup, T. Scott, Lönnqvist, Jouko, Suvisaari, Jaana, Maher, Brion S., Maier, Wolfgang, Mallet, Jacques, McDonald, Colm, McIntosh, Andrew M., Blackwood, Douglas H.R., Metspalu, Andres, Milani, Lili, Milanova, Vihra, Mokrab, Younes, Collier, David A., Müller-Myhsok, Bertram, Murphy, Kieran C., Murray, Robin M., Powell, John, Myin-Germeys, Inez, Van Os, Jim, Nenadic, Igor, Nertney, Deborah A., Nestadt, Gerald, Pulver, Ann E., Nicodemus, Kristin K., Nisenbaum, Laura, Nordin, Annelie, Adolfsson, Rolf, O'Callaghan, Eadbhard, Oh, Sang-Yun, O'Neill, F. Anthony, Paunio, Tiina, Pietiläinen, Olli, Perkins, Diana O., Quested, Digby, Savitz, Adam, Li, Qingqin S., Schwab, Sibylle G., Shi, Jianxin, Spencer, Chris C.A., Thirumalai, Srinivas, Veijola, Juha, Waddington, John, Walsh, Dermot, Wildenauer, Dieter B., Bramon, Elvira, Darvasi, Ariel, Posthuma, Danielle, St. Clair, David, Shanta, Omar, Klein, Marieke, Park, Peter J., Weinberger, Daniel, Moran, John V., Gage, Fred H., Vaccarino, Flora M., Gleeson, Joseph, Mathern, Gary, Courchesne, Eric, Roy, Subhojit, Bizzotto, Sara, Coulter, Michael, Dias, Caroline, D'Gama, Alissa, Ganz, Javier, Hill, Robert, Huang, August Yue, Khoshkhoo, Sattar, Kim, Sonia, Lodato, Michael, Miller, Michael, Borges-Monroy, Rebeca, Rodin, Rachel, Zhou, Zinan, Bohrson, Craig, Chu, Chong, Cortes-Ciriano, Isidro, Dou, Yanmei, Galor, Alon, Gulhan, Doga, Kwon, Minseok, Luquette, Joe, Viswanadham, Vinay, Jones, Attila, Rosenbluh, Chaggai, Cho, Sean, Langmead, Ben, Thorpe, Jeremy, Erwin, Jennifer, Jaffe, Andrew, McConnell, Michael, Narurkar, Rujuta, Paquola, Apua, Shin, Jooheon, Straub, Richard, Abyzov, Alexej, Bae, Taejeong, Jang, Yeongjun, Wang, Yifan, Gage, Fred, Linker, Sara, Reed, Patrick, Wang, Meiyan, Urban, Alexander, Zhou, Bo, Zhu, Xiaowei, Pattni, Reenal, Amero, Aitor Serres, Juan, David, Lobon, Irene, Marques-Bonet, Tomas, Moruno, Manuel Solis, Perez, Raquel Garcia, Povolotskaya, Inna, Soriano, Eduardo, Averbuj, Dan, Ball, Laurel, Breuss, Martin, Yang, Xiaoxu, Chung, Changuk, Emery, Sarah B., Flasch, Diane A., Kidd, Jeffrey M., Kopera, Huira C., Kwan, Kenneth Y., Mills, Ryan E., Moldovan, John B., Sun, Chen, Zhao, Xuefang, Zhou, Weichen, Frisbie, Trenton J., Cherskov, Adriana, Fasching, Liana, Jourdon, Alexandre, Pochareddy, Sirisha, Scuderi, Soraya, Sestan, Nenad, Maury, Eduardo A., Sherman, Maxwell A., Genovese, Giulio, Gilgenast, Thomas G., Kamath, Tushar, Burris, S.J., Rajarajan, Prashanth, Flaherty, Erin, Akbarian, Schahram, Chess, Andrew, McCarroll, Steven A., Loh, Po-Ru, Phillips-Cremins, Jennifer E., Brennand, Kristen J., Macosko, Evan Z., Walters, James T.R., O’Donovan, Michael, Sullivan, Patrick, Sebat, Jonathan, Lee, Eunjung A., and Walsh, Christopher A.
- Published
- 2023
- Full Text
- View/download PDF
3. Publisher Correction: Assessment of the gene mosaicism burden in blood and its implications for immune disorders
- Author
-
Solís-Moruno, Manuel, Mensa-Vilaró, Anna, Batlle-Masó, Laura, Lobón, Irene, Bonet, Núria, Marquès-Bonet, Tomàs, Aróstegui, Juan I., and Casals, Ferran
- Published
- 2021
- Full Text
- View/download PDF
4. Epigenomic profiling of primate lymphoblastoid cell lines reveals the evolutionary patterns of epigenetic activities in gene regulatory architectures
- Author
-
García-Pérez, Raquel, Esteller-Cucala, Paula, Mas, Glòria, Lobón, Irene, Di Carlo, Valerio, Riera, Meritxell, Kuhlwilm, Martin, Navarro, Arcadi, Blancher, Antoine, Di Croce, Luciano, Gómez-Skarmeta, José Luis, Juan, David, and Marquès-Bonet, Tomàs
- Published
- 2021
- Full Text
- View/download PDF
5. Assessment of the gene mosaicism burden in blood and its implications for immune disorders
- Author
-
Solís-Moruno, Manuel, Mensa-Vilaró, Anna, Batlle-Masó, Laura, Lobón, Irene, Bonet, Núria, Marquès-Bonet, Tomàs, Aróstegui, Juan I., and Casals, Ferran
- Published
- 2021
- Full Text
- View/download PDF
6. Ghost admixture in eastern gorillas
- Author
-
Vienna Science and Technology Fund, European Research Council, European Commission, Agencia Estatal de Investigación (España), Ministerio de Ciencia e Innovación (España), Generalitat de Catalunya, Ministerio de Ciencia, Innovación y Universidades (España), Wellcome, Swedish Research Council, John Templeton Foundation, Wellcome Trust, Monash University, Manuel, Marc de [0000-0002-1245-0127], Lobón, Irene [0000-0003-1170-9915], Alvarez-Estape, Marina [0000-0001-8242-1092], Han, Sojung [0000-0002-6113-1042], Juan, David [0000-0003-1912-9667], Lao, Oscar [0000-0002-8525-9649], Prado-Martinez, Javier [0000-0001-5402-2721], Marqués-Bonet, Tomàs [0000-0002-5597-3075], Kuhlwilm, Martin [0000-0002-0115-1797], Pawar, Harvinder, Rymbekova, Aigerim, Cuadros-Espinoza, Sebastian, Huang, Xin, Manuel, Marc de, van der Valk, Tom, Lobón, Irene, Alvarez-Estape, Marina, Haber, Marc, Dolgova, Olga, Han, Sojung, Esteller-Cucala, Paula, Juan, David, Ayub, Qasim, Bautista, Ruben, Kelley, Joanna L., Cornejo, Omar E., Lao, Oscar, Andrés, Aida M., Guschanski, Katerina, Ssebide, Benard, Cranfield, Mike, Tyler-Smith, Chris, Xue, Yali, Prado-Martinez, Javier, Marqués-Bonet, Tomàs, Kuhlwilm, Martin, Vienna Science and Technology Fund, European Research Council, European Commission, Agencia Estatal de Investigación (España), Ministerio de Ciencia e Innovación (España), Generalitat de Catalunya, Ministerio de Ciencia, Innovación y Universidades (España), Wellcome, Swedish Research Council, John Templeton Foundation, Wellcome Trust, Monash University, Manuel, Marc de [0000-0002-1245-0127], Lobón, Irene [0000-0003-1170-9915], Alvarez-Estape, Marina [0000-0001-8242-1092], Han, Sojung [0000-0002-6113-1042], Juan, David [0000-0003-1912-9667], Lao, Oscar [0000-0002-8525-9649], Prado-Martinez, Javier [0000-0001-5402-2721], Marqués-Bonet, Tomàs [0000-0002-5597-3075], Kuhlwilm, Martin [0000-0002-0115-1797], Pawar, Harvinder, Rymbekova, Aigerim, Cuadros-Espinoza, Sebastian, Huang, Xin, Manuel, Marc de, van der Valk, Tom, Lobón, Irene, Alvarez-Estape, Marina, Haber, Marc, Dolgova, Olga, Han, Sojung, Esteller-Cucala, Paula, Juan, David, Ayub, Qasim, Bautista, Ruben, Kelley, Joanna L., Cornejo, Omar E., Lao, Oscar, Andrés, Aida M., Guschanski, Katerina, Ssebide, Benard, Cranfield, Mike, Tyler-Smith, Chris, Xue, Yali, Prado-Martinez, Javier, Marqués-Bonet, Tomàs, and Kuhlwilm, Martin
- Abstract
Archaic admixture has had a substantial impact on human evolution with multiple events across different clades, including from extinct hominins such as Neanderthals and Denisovans into modern humans. In great apes, archaic admixture has been identified in chimpanzees and bonobos but the possibility of such events has not been explored in other species. Here, we address this question using high-coverage whole-genome sequences from all four extant gorilla subspecies, including six newly sequenced eastern gorillas from previously unsampled geographic regions. Using approximate Bayesian computation with neural networks to model the demographic history of gorillas, we find a signature of admixture from an archaic ‘ghost’ lineage into the common ancestor of eastern gorillas but not western gorillas. We infer that up to 3% of the genome of these individuals is introgressed from an archaic lineage that diverged more than 3 million years ago from the common ancestor of all extant gorillas. This introgression event took place before the split of mountain and eastern lowland gorillas, probably more than 40 thousand years ago and may have influenced perception of bitter taste in eastern gorillas. When comparing the introgression landscapes of gorillas, humans and bonobos, we find a consistent depletion of introgressed fragments on the X chromosome across these species. However, depletion in protein-coding content is not detectable in eastern gorillas, possibly as a consequence of stronger genetic drift in this species.
- Published
- 2023
7. Mountain gorilla genomes reveal the impact of long-term population decline and inbreeding
- Author
-
Xue, Yali, Prado-Martinez, Javier, Sudmant, Peter H., Narasimhan, Vagheesh, Ayub, Qasim, Szpak, Michal, Frandsen, Peter, Chen, Yuan, Yngvadottir, Bryndis, Cooper, David N., de Manuel, Marc, Hernandez-Rodriguez, Jessica, Lobon, Irene, Siegismund, Hans R., Pagani, Luca, Quail, Michael A., Hvilsom, Christina, Mudakikwa, Antoine, Eichler, Evan E., Cranfield, Michael R., Marques-Bonet, Tomas, Tyler-Smith, Chris, and Scally, Aylwyn
- Published
- 2015
8. Comprehensive identification of somatic nucleotide variants in human brain tissue
- Author
-
National Institute of Mental Health (US), Wang, Yifan, Bae, Taejeong, Thorpe, Jeremy, Sherman, Maxwell A., Jones, Attila G., Cho, Sean, Daily, Kenneth, Dou, Yanmei, Ganz, Javier, Galor, Alon, Lobón, Irene, Pattni, Reenal, Rosenbluh, Chaggai, Tomasi, Simone, Tomasini, Livia, Yang, Xiaoxu, Zhou, Bo, Akbarian, Schahram, Ball, Laurel L., Bizzotto, Sara, Emery, Sarah B., Doan, Ryan, Fasching, Liana, Jang, Yeongjun, Juan, David, Lizano, Esther, Luquette, Lovelace J., Moldovan, John B., Narurkar, Rujuta, Oetjens, Matthew T., Rodin, Rachel E., Sekar, Shobana, Shin, Joo Heon, Soriano, Eduardo, Straub, Richard E., Zhou, Weichen, Chess, Andrew, Gleeson, Joseph G., Marqués-Bonet, Tomàs, Park, Peter J., Peters, Mette A., Pevsner, Jonathan, Walsh, Christopher A., Weinberger, Daniel R., Brain Somatic Mosaicism Network, Vaccarino, Flora M., Moran, John V., Urban, Alexander E., Kidd, Jeffrey M., Mills, Ryan E., Abyzov, Alexej, National Institute of Mental Health (US), Wang, Yifan, Bae, Taejeong, Thorpe, Jeremy, Sherman, Maxwell A., Jones, Attila G., Cho, Sean, Daily, Kenneth, Dou, Yanmei, Ganz, Javier, Galor, Alon, Lobón, Irene, Pattni, Reenal, Rosenbluh, Chaggai, Tomasi, Simone, Tomasini, Livia, Yang, Xiaoxu, Zhou, Bo, Akbarian, Schahram, Ball, Laurel L., Bizzotto, Sara, Emery, Sarah B., Doan, Ryan, Fasching, Liana, Jang, Yeongjun, Juan, David, Lizano, Esther, Luquette, Lovelace J., Moldovan, John B., Narurkar, Rujuta, Oetjens, Matthew T., Rodin, Rachel E., Sekar, Shobana, Shin, Joo Heon, Soriano, Eduardo, Straub, Richard E., Zhou, Weichen, Chess, Andrew, Gleeson, Joseph G., Marqués-Bonet, Tomàs, Park, Peter J., Peters, Mette A., Pevsner, Jonathan, Walsh, Christopher A., Weinberger, Daniel R., Brain Somatic Mosaicism Network, Vaccarino, Flora M., Moran, John V., Urban, Alexander E., Kidd, Jeffrey M., Mills, Ryan E., and Abyzov, Alexej
- Abstract
[Background] Post-zygotic mutations incurred during DNA replication, DNA repair, and other cellular processes lead to somatic mosaicism. Somatic mosaicism is an established cause of various diseases, including cancers. However, detecting mosaic variants in DNA from non-cancerous somatic tissues poses significant challenges, particularly if the variants only are present in a small fraction of cells., [Results] Here, the Brain Somatic Mosaicism Network conducts a coordinated, multi-institutional study to examine the ability of existing methods to detect simulated somatic single-nucleotide variants (SNVs) in DNA mixing experiments, generate multiple replicates of whole-genome sequencing data from the dorsolateral prefrontal cortex, other brain regions, dura mater, and dural fibroblasts of a single neurotypical individual, devise strategies to discover somatic SNVs, and apply various approaches to validate somatic SNVs. These efforts lead to the identification of 43 bona fide somatic SNVs that range in variant allele fractions from ~ 0.005 to ~ 0.28. Guided by these results, we devise best practices for calling mosaic SNVs from 250× whole-genome sequencing data in the accessible portion of the human genome that achieve 90% specificity and sensitivity. Finally, we demonstrate that analysis of multiple bulk DNA samples from a single individual allows the reconstruction of early developmental cell lineage trees., [Conclusions] This study provides a unified set of best practices to detect somatic SNVs in non-cancerous tissues. The data and methods are freely available to the scientific community and should serve as a guide to assess the contributions of somatic SNVs to neuropsychiatric diseases.
- Published
- 2021
9. Assessment of the gene mosaicism burden in blood and its implications for immune disorders
- Author
-
Ministerio de Economía y Competitividad (España), Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), European Commission, Generalitat de Catalunya, Howard Hughes Medical Institute, Fundación la Caixa, Instituto de Salud Carlos III, Solís-Moruno, Manuel, Mensa-Vilaró, Anna, Batlle-Masó, Laura, Lobón, Irene, Bonet, Núria, Marqués-Bonet, Tomàs, Arostegui, Juan Ignacio, Casals, Ferran, Ministerio de Economía y Competitividad (España), Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), European Commission, Generalitat de Catalunya, Howard Hughes Medical Institute, Fundación la Caixa, Instituto de Salud Carlos III, Solís-Moruno, Manuel, Mensa-Vilaró, Anna, Batlle-Masó, Laura, Lobón, Irene, Bonet, Núria, Marqués-Bonet, Tomàs, Arostegui, Juan Ignacio, and Casals, Ferran
- Abstract
There are increasing evidences showing the contribution of somatic genetic variants to non-cancer diseases. However, their detection using massive parallel sequencing methods still has important limitations. In addition, the relative importance and dynamics of somatic variation in healthy tissues are not fully understood. We performed high-depth whole-exome sequencing in 16 samples from patients with a previously determined pathogenic somatic variant for a primary immunodeficiency and tested different variant callers detection ability. Subsequently, we explored the load of somatic variants in the whole blood of these individuals and validated it by amplicon-based deep sequencing. Variant callers allowing low frequency read thresholds were able to detect most of the variants, even at very low frequencies in the tissue. The genetic load of somatic coding variants detectable in whole blood is low, ranging from 1 to 2 variants in our dataset, except for one case with 17 variants compatible with clonal haematopoiesis under genetic drift. Because of the ability we demonstrated to detect this type of genetic variation, and its relevant role in disorders such as primary immunodeficiencies, we suggest considering this model of gene mosaicism in future genetic studies and considering revisiting previous massive parallel sequencing data in patients with negative results.
- Published
- 2021
10. Epigenomic profiling of primate lymphoblastoid cell lines reveals the evolutionary patterns of epigenetic activities in gene regulatory architectures
- Author
-
Ministerio de Ciencia e Innovación (España), Generalitat de Catalunya, German Research Foundation, Fundación la Caixa, Ministerio de Economía y Competitividad (España), Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), European Commission, European Research Council, Howard Hughes Medical Institute, Fundación BBVA, Instituto Nacional de Bioinformática (España), Ministerio de Educación, Cultura y Deporte (España), García-Pérez, Raquel, Esteller-Cucala, Paula, Mas, Glòria, Lobón, Irene, Di Carlo, Valerio, Riera, Meritxell, Kuhlwilm, Martin, Navarro, Arcadi, Blancher, Antoine, Croce, Luciano di, Gómez-Skarmeta, José Luis, Juan, David, Marqués-Bonet, Tomàs, Ministerio de Ciencia e Innovación (España), Generalitat de Catalunya, German Research Foundation, Fundación la Caixa, Ministerio de Economía y Competitividad (España), Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), European Commission, European Research Council, Howard Hughes Medical Institute, Fundación BBVA, Instituto Nacional de Bioinformática (España), Ministerio de Educación, Cultura y Deporte (España), García-Pérez, Raquel, Esteller-Cucala, Paula, Mas, Glòria, Lobón, Irene, Di Carlo, Valerio, Riera, Meritxell, Kuhlwilm, Martin, Navarro, Arcadi, Blancher, Antoine, Croce, Luciano di, Gómez-Skarmeta, José Luis, Juan, David, and Marqués-Bonet, Tomàs
- Abstract
Changes in the epigenetic regulation of gene expression have a central role in evolution. Here, we extensively profiled a panel of human, chimpanzee, gorilla, orangutan, and macaque lymphoblastoid cell lines (LCLs), using ChIP-seq for five histone marks, ATAC-seq and RNA-seq, further complemented with whole genome sequencing (WGS) and whole genome bisulfite sequencing (WGBS). We annotated regulatory elements (RE) and integrated chromatin contact maps to define gene regulatory architectures, creating the largest catalog of RE in primates to date. We report that epigenetic conservation and its correlation with sequence conservation in primates depends on the activity state of the regulatory element. Our gene regulatory architectures reveal the coordination of different types of components and highlight the role of promoters and intragenic enhancers (gE) in the regulation of gene expression. We observe that most regulatory changes occur in weakly active gE. Remarkably, novel human-specific gE with weak activities are enriched in human-specific nucleotide changes. These elements appear in genes with signals of positive selection and human acceleration, tissue-specific expression, and particular functional enrichments, suggesting that the regulatory evolution of these genes may have contributed to human adaptation.
- Published
- 2021
11. Gene regulatory architectures dissect the evolutionary dynamics of regulatory elements in humans and non-human primates
- Author
-
García-Pérez, Raquel, Esteller-Cucala, Paula, Mas, Glòria, Lobón, Irene, Di Carlo, Valerio, Riera, Meritxell, Kuhlwilm, Martin, Navarro, Arcadi, Blancher, Antoine, Di Croce, Luciano, Gómez-Skarmeta, José Luis, Juan, David, and Marquès-Bonet, Tomàs
- Abstract
Trabajo presentado en el VII Congress of the Spanish Society for Evolutionary Biology / VII Congreso de la Sociedad Española de Biología Evolutiva (SESBE VII), celebrado en Sevilla del 5 al 7 de febrero de 2020., Genes undergoing substantial evolutionary shifts in their expression profiles are often modulated by critical epigenomic changes that are among the primary targets of selection in evolution. Here, we investigate the evolution of epigenetic regulatory activities and their interplay with gene expression in human and non-human primate lineages. We extensively profiled a new panel of human and non-human primate lymphoblastoid cell lines using a variety of NGS techniques and integrated genome-wide chromatin contact maps to define gene regulatory architectures. We observe that epigenetic and sequence conservation are coupled in regulatory elements and reflect the impact of their activity on gene expression. The addition or removal of strong and poised promoters and intragenic enhancers is frequent in gene expression changes during recent primate evolution. In contrast, novel human-specific weak intragenic enhancers, dormant in our cell lines, have emerged in genes showing signals of recent adaptive selection, suggesting that they echo important regulatory innovations in other cell types. Among the genes targeted by these regulatory innovations, we find key candidate drivers of recently evolved human traits, such as FOXP2 or ROBO1 for speech and language acquisition, and PALMD for neocortex expansion, thus highlighting the importance of regulatory changes in human evolution.
- Published
- 2020
12. Gene regulatory architectures dissect the evolutionary dynamics of regulatory elements in humans and non-human primates
- Author
-
Juan, David, García-Pérez, Raquel, Esteller-Cucala, Paula, Mas, Glòria, Lobón, Irene, Di Carlo, Valerio, Riera, Meritxell, Kuhlwilm, Martin, Navarro, Arcadi, Blancher, Antoine, Croce, Luciano di, Gómez-Skarmeta, José Luis, Marqués-Bonet, Tomàs, Juan, David, García-Pérez, Raquel, Esteller-Cucala, Paula, Mas, Glòria, Lobón, Irene, Di Carlo, Valerio, Riera, Meritxell, Kuhlwilm, Martin, Navarro, Arcadi, Blancher, Antoine, Croce, Luciano di, Gómez-Skarmeta, José Luis, and Marqués-Bonet, Tomàs
- Abstract
Genes undergoing substantial evolutionary shifts in their expression profiles are often modulated by critical epigenomic changes that are among the primary targets of selection in evolution. Here, we investigate the evolution of epigenetic regulatory activities and their interplay with gene expression in human and non-human primate lineages. We extensively profiled a new panel of human and non-human primate lymphoblastoid cell lines using a variety of NGS techniques and integrated genome-wide chromatin contact maps to define gene regulatory architectures. We observe that epigenetic and sequence conservation are coupled in regulatory elements and reflect the impact of their activity on gene expression. The addition or removal of strong and poised promoters and intragenic enhancers is frequent in gene expression changes during recent primate evolution. In contrast, novel human-specific weak intragenic enhancers, dormant in our cell lines, have emerged in genes showing signals of recent adaptive selection, suggesting that they echo important regulatory innovations in other cell types. Among the genes targeted by these regulatory innovations, we find key candidate drivers of recently evolved human traits, such as FOXP2 or ROBO1 for speech and language acquisition, and PALMD for neocortex expansion, thus highlighting the importance of regulatory changes in human evolution.
- Published
- 2020
13. Revisión del tratamiento farmacológico de la esclerosis múltiple. A propósito de un caso
- Author
-
Sánchez Lobón, Irene, Villegas Lama, Isabel, and Universidad de Sevilla. Departamento de Farmacología
- Subjects
Extavia ,MS (acrónimo anglosajón de Esclerosis Múltiple) ,Adverse events ,Plegridy - Abstract
La esclerosis múltiple es una enfermedad desmielinizante que afecta al sistema nervioso central (SNC), es decir, se produce la destrucción de la vaina de mielina de las neuronas. Como consecuencia, se origina una alteración en la conducción del impulso nervioso apareciendo así los síntomas que varían desde neuritis óptica a síntomas motores. Y aunque la causa de dicha enfermedad es desconocida, se conocen dos factores predisponentes como son: los factores genéticos y los factores ambientales. En la actualidad, no existe un tratamiento curativo, pero existen tratamientos para prevenir la discapacidad y mejorar los síntomas. Así pues, el mejor tratamiento es el que cumple con estos objetivos y presenta el menor número de reacciones adversas, siendo el tratamiento de primera línea los interferones beta. El objetivo principal de este estudio ha sido conocer las causas del cambio de tratamiento que se llevó a cabo en nuestro caso clínico, es decir, el cambio de interferón beta-1b (Extavia®) a peginterferón beta-1a (Plegridy®), ocupando ambos la misma linealidad en el tratamiento de la esclerosis múltiple. Para ello, se ha llevado a cabo una revisión bibliográfica de la literatura científica, disponible en PubMed y Scopus, sobre la eficacia y los efectos adversos (EA) de ambos fármacos. Se han incluido todos los estudios en humanos desde el año 2014 hasta la fecha de hoy. Entre los resultados más significativos encontramos que ambos fármacos son usados como primera línea en el tratamiento de dicha enfermedad y sus EA son similares. Sin embargo, en el caso de peginterferón beta-1a (Plegridy®), su molécula se encuentra pegilada, ofreciéndole una gran ventaja sobre interferón beta-1b (Extavia®), ya que aumenta la vida media del fármaco en el organismo conllevando a una disminución de la frecuencia de administración de dicho agente. Por lo tanto, se disminuyen los EA y como consecuencia se produce un aumento de la adherencia al tratamiento. Tras la revisión, proponemos un tríptico informativo para el paciente y cuidadores con objeto de contribuir a su conocimiento de la enfermedad, y a un abordaje terapéutico que facilite al paciente la adherencia al tratamiento. Universidad de Sevilla. Grado en Farmacia
- Published
- 2019
14. Epigenomic profiling of primate LCLs reveals the evolutionary patterns of epigenetic activities in gene regulatory architectures
- Author
-
García-Pérez, Raquel, primary, Esteller-Cucala, Paula, additional, Mas, Glòria, additional, Lobón, Irene, additional, Di Carlo, Valerio, additional, Riera, Meritxell, additional, Kuhlwilm, Martin, additional, Navarro, Arcadi, additional, Blancher, Antoine, additional, Di Croce, Luciano, additional, Gómez-Skarmeta, José Luis, additional, Juan, David, additional, and Marquès-Bonet, Tomàs, additional
- Published
- 2019
- Full Text
- View/download PDF
15. Revisión del tratamiento farmacológico de la esclerosis múltiple. A propósito de un caso
- Author
-
Villegas Lama, Isabel, Universidad de Sevilla. Departamento de Farmacología, Sánchez Lobón, Irene, Villegas Lama, Isabel, Universidad de Sevilla. Departamento de Farmacología, and Sánchez Lobón, Irene
- Abstract
La esclerosis múltiple es una enfermedad desmielinizante que afecta al sistema nervioso central (SNC), es decir, se produce la destrucción de la vaina de mielina de las neuronas. Como consecuencia, se origina una alteración en la conducción del impulso nervioso apareciendo así los síntomas que varían desde neuritis óptica a síntomas motores. Y aunque la causa de dicha enfermedad es desconocida, se conocen dos factores predisponentes como son: los factores genéticos y los factores ambientales. En la actualidad, no existe un tratamiento curativo, pero existen tratamientos para prevenir la discapacidad y mejorar los síntomas. Así pues, el mejor tratamiento es el que cumple con estos objetivos y presenta el menor número de reacciones adversas, siendo el tratamiento de primera línea los interferones beta. El objetivo principal de este estudio ha sido conocer las causas del cambio de tratamiento que se llevó a cabo en nuestro caso clínico, es decir, el cambio de interferón beta-1b (Extavia®) a peginterferón beta-1a (Plegridy®), ocupando ambos la misma linealidad en el tratamiento de la esclerosis múltiple. Para ello, se ha llevado a cabo una revisión bibliográfica de la literatura científica, disponible en PubMed y Scopus, sobre la eficacia y los efectos adversos (EA) de ambos fármacos. Se han incluido todos los estudios en humanos desde el año 2014 hasta la fecha de hoy. Entre los resultados más significativos encontramos que ambos fármacos son usados como primera línea en el tratamiento de dicha enfermedad y sus EA son similares. Sin embargo, en el caso de peginterferón beta-1a (Plegridy®), su molécula se encuentra pegilada, ofreciéndole una gran ventaja sobre interferón beta-1b (Extavia®), ya que aumenta la vida media del fármaco en el organismo conllevando a una disminución de la frecuencia de administración de dicho agente. Por lo tanto, se disminuyen los EA y como consecuencia se produce un aumento de la adherencia al tratamiento. Tras la revisión, proponemos un trí
- Published
- 2019
16. Demographic History of the Genus Pan Inferred from Whole Mitochondrial Genome Reconstructions
- Author
-
Generalitat de Catalunya, EMBO, Ministerio de Economía y Competitividad (España), European Commission, Fundació Barcelona Zoo, Università degli Studi di Ferrara, Lobón, Irene, Manuel, Marc de, Hernandez, Jessica, Comas, David, Navarro, Arcadi, Marqués-Bonet, Tomàs, Generalitat de Catalunya, EMBO, Ministerio de Economía y Competitividad (España), European Commission, Fundació Barcelona Zoo, Università degli Studi di Ferrara, Lobón, Irene, Manuel, Marc de, Hernandez, Jessica, Comas, David, Navarro, Arcadi, and Marqués-Bonet, Tomàs
- Abstract
The genus Pan is the closest genus to our own and it includes two species, Pan paniscus (bonobos) and Pan troglodytes (chimpanzees). The later is constituted by four subspecies, all highly endangered. The study of the Pan genera has been incessantly complicated by the intricate relationship among subspecies and the statistical limitations imposed by the reduced number of samples or genomic markers analyzed. Here, we present a new method to reconstruct complete mitochondrial genomes (mitogenomes) from whole genome shotgun (WGS) datasets, mtArchitect, showing that its reconstructions are highly accurate and consistent with long-range PCR mitogenomes. We used this approach to build the mitochondrial genomes of 20 newly sequenced samples which, together with available genomes, allowed us to analyze the hitherto most complete Pan mitochondrial genome dataset including 156 chimpanzee and 44 bonobo individuals, with a proportional contribution from all chimpanzee subspecies. We estimated the separation time between chimpanzees and bonobos around 1.15 million years ago (Mya) [0.81–1.49]. Further, we found that under the most probable genealogical model the two clades of chimpanzees, Western + Nigeria-Cameroon and Central + Eastern, separated at 0.59 Mya [0.41–0.78] with further internal separations at 0.32 Mya [0.22–0.43] and 0.16 Mya [0.17–0.34], respectively. Finally, for a subset of our samples, we compared nuclear versus mitochondrial genomes and we found that chimpanzee subspecies have different patterns of nuclear and mitochondrial diversity, which could be a result of either processes affecting the mitochondrial genome, such as hitchhiking or background selection, or a result of population dynamics.
- Published
- 2016
17. A common genetic origin for early farmers from Mediterranean Cardial and Central European LBK cultures
- Author
-
Olalde, Iñigo, Schroeder, Hannes, Sandoval Velasco, Marcela, Vinner, Lasse, Lobón, Irene, Ramirez, Oscar, Civit, Sergi, Borja, Pablo García, Salazar-García, Domingo C., Talamo, Sahra, Fullola, Josep María, Oms, Francesc Xavier, Pedro, Mireia, Martínez, Pablo, Sanz, Montserrat, Daura, Joan, Zilhão, João, Marquès-Bonet, Tomás, Gilbert, M. Thomas P., Lalueza-Fox, Carles, Olalde, Iñigo, Schroeder, Hannes, Sandoval Velasco, Marcela, Vinner, Lasse, Lobón, Irene, Ramirez, Oscar, Civit, Sergi, Borja, Pablo García, Salazar-García, Domingo C., Talamo, Sahra, Fullola, Josep María, Oms, Francesc Xavier, Pedro, Mireia, Martínez, Pablo, Sanz, Montserrat, Daura, Joan, Zilhão, João, Marquès-Bonet, Tomás, Gilbert, M. Thomas P., and Lalueza-Fox, Carles
- Published
- 2015
18. A Common Genetic Origin for Early Farmers from Mediterranean Cardial and Central European LBK Cultures
- Author
-
Danish National Research Foundation, Generalitat de Catalunya, Ministerio de Ciencia e Innovación (España), European Research Council, European Commission, Fundación BBVA, Eusko Jaurlaritza, Fundação para a Ciência e a Tecnologia (Portugal), Olalde, Iñigo, Lobón, Irene, Ramírez, Óscar, Marqués-Bonet, Tomàs, Lalueza-Fox, Carles, Danish National Research Foundation, Generalitat de Catalunya, Ministerio de Ciencia e Innovación (España), European Research Council, European Commission, Fundación BBVA, Eusko Jaurlaritza, Fundação para a Ciência e a Tecnologia (Portugal), Olalde, Iñigo, Lobón, Irene, Ramírez, Óscar, Marqués-Bonet, Tomàs, and Lalueza-Fox, Carles
- Abstract
The spread of farming out of the Balkans and into the rest of Europe followed two distinct routes: An initial expansion represented by the Impressa and Cardial traditions, which followed the Northern Mediterranean coastline; and another expansion represented by the LBK (Linearbandkeramik) tradition, which followed the Danube River into Central Europe. Although genomic data now exist from samples representing the second migration, such data have yet to be successfully generated from the initial Mediterranean migration. To address this, we generated the complete genome of a 7,400-year-old Cardial individual (CB13) from Cova Bonica in Vallirana (Barcelona), as well as partial nuclear data from five others excavated from different sites in Spain and Portugal. CB13 clusters with all previously sequenced early European farmers and modern-day Sardinians. Furthermore, our analyses suggest that both Cardial and LBK peoples derived from a common ancient population located in or around the Balkan Peninsula. The Iberian Cardial genome also carries a discernible hunter–gatherer genetic signature that likely was not acquired by admixture with local Iberian foragers. Our results indicate that retrieving ancient genomes from similarly warm Mediterranean environments such as the Near East is technically feasible.
- Published
- 2015
19. Mountain gorilla genomes reveal the impact of long-term population decline and inbreeding
- Author
-
Ministerio de Ciencia e Innovación (España), European Commission, National Institutes of Health (US), Wellcome Trust, Royal Society (UK), Xue, Yali, Prado-Martinez, Javier, Manuel, Marc de, Hernández-Rodríguez, Jessica, Lobón, Irene, Marqués-Bonet, Tomàs, Scally, Aylwyn, Ministerio de Ciencia e Innovación (España), European Commission, National Institutes of Health (US), Wellcome Trust, Royal Society (UK), Xue, Yali, Prado-Martinez, Javier, Manuel, Marc de, Hernández-Rodríguez, Jessica, Lobón, Irene, Marqués-Bonet, Tomàs, and Scally, Aylwyn
- Abstract
Mountain gorillas are an endangered great ape subspecies and a prominent focus for conservation, yet we know little about their genomic diversity and evolutionary past. We sequenced whole genomes from multiple wild individuals and compared the genomes of all four Gorilla subspecies. We found that the two eastern subspecies have experienced a prolonged population decline over the past 100,000 years, resulting in very low genetic diversity and an increased overall burden of deleterious variation. A further recent decline in the mountain gorilla population has led to extensive inbreeding, such that individuals are typically homozygous at 34% of their sequence, leading to the purging of severely deleterious recessive mutations from the population. We discuss the causes of their decline and the consequences for their future survival. © 2015, American Association for the Advancement of Science. All rights reserved.
- Published
- 2015
20. A Common Genetic Origin for Early Farmers from Mediterranean Cardial and Central European LBK Cultures
- Author
-
Olalde, Iñigo, primary, Schroeder, Hannes, additional, Sandoval-Velasco, Marcela, additional, Vinner, Lasse, additional, Lobón, Irene, additional, Ramirez, Oscar, additional, Civit, Sergi, additional, García Borja, Pablo, additional, Salazar-García, Domingo C., additional, Talamo, Sahra, additional, María Fullola, Josep, additional, Xavier Oms, Francesc, additional, Pedro, Mireia, additional, Martínez, Pablo, additional, Sanz, Montserrat, additional, Daura, Joan, additional, Zilhão, João, additional, Marquès-Bonet, Tomàs, additional, Gilbert, M. Thomas P., additional, and Lalueza-Fox, Carles, additional
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.